A NEW CATEGORY
Rethinking the Way We Treat Serious Health Conditions
AppliedVR is the first company to make virtual reality-based therapeutics widely available in healthcare. We’re committed to the development of safe, effective, clinically tested VRx treatments that improve the outcomes of those with serious health conditions. Working with more than 60,000 patients in 240 hospitals and 1,500 patient homes, we’ve generated significant real-world evidence that retraining the way the brain perceives pain is a promising new treatment path. Our RelieVRx (formerly EaseVRx) is the first and only FDA-authorized at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).1,2
WORLD-CLASS RESEARCH
Some of Our
Collaborators
Our Pipeline
PHASE 1
DISCOVERY
PHASE 2
EFFICACY
PHASE 3
PIVOTAL TRIAL
PHASE 4
FDA-authorized
Chronic Lower Back Pain
General pain and anxiety management
Fibromyalgia
Opioid sparing treatment for chronic pain
Post Surgical Pain - Total Knee Replacement
Opioid sparing treatment for acute postoperative pain
Cancer Related Anxiety
Treatment for generalized anxiety
Rheumatoid Arthritis
General pain and anxiety management
Interested in Partnering
on Future Clinical Studies?
Get in Touch
Indication for Use
RelieVRx is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.
References
RelieVRx [instructions for use]. Van Nuys, CA: AppliedVR, Inc.; 2021.
AppliedVR Press Release. Accessed January 18, 2022.
RelieVRx was formerly known as EaseVRx.